Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors.
about
Enteric-coated mycophenolate sodium containing GvHD prophylaxis reduces GvHD rate after allogeneic HSCT.Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant periodIntensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Pharmacogenetics and immunosuppressive drugs.Optimizing drug therapy in pediatric SCT: focus on pharmacokinetics.Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients.The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.Mycophenolic Acid and Its Metabolites in Kidney Transplant Recipients: A Semimechanistic Enterohepatic Circulation Model to Improve Estimating Exposure.Monitoring mycophenolate mofetil is necessary for the effective prophylaxis of acute GVHD after cord blood transplantation.The Inhibition of UDP-Glucuronosyltransferase (UGT) Isoforms by Praeruptorin A and B.
P2860
Q30315933-3211A37F-4638-4D8C-A953-A5539084AB9FQ34570937-972FE002-D1C1-422A-B34C-950762F355CEQ35533371-CFA5EFB3-F03D-45C1-967D-C782347D4186Q36777485-284C688E-6513-4572-ACBF-B3C475AADD15Q38170321-CDE9062B-C48A-485D-AE44-DC90381CE465Q38258677-BA59ADA4-1786-44BF-A149-2AE4FF89AB6FQ38262916-3785F9E6-5C9D-449A-B9D7-95CED400EB72Q38817096-86B85DA0-F6F8-4CED-AB62-C37E1BFD806EQ40396484-5E656FD6-F5B4-4DA3-9C99-113F7F3CD8E7Q47678205-224BC685-A0A9-4CC1-A2D2-DABD01CBE03FQ48252498-A6B75819-B958-4B13-84BF-D99E2B39A71DQ48253938-C38F8B4C-63A4-4CFF-8D29-972D353C9EBBQ51566007-FE51F52F-6771-4675-A269-02F6C6C7BF70
P2860
Population pharmacokinetics of unbound mycophenolic acid in adult allogeneic haematopoietic cell transplantation: effect of pharmacogenetic factors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Population pharmacokinetics of ...... ct of pharmacogenetic factors.
@ast
Population pharmacokinetics of ...... ct of pharmacogenetic factors.
@en
type
label
Population pharmacokinetics of ...... ct of pharmacogenetic factors.
@ast
Population pharmacokinetics of ...... ct of pharmacogenetic factors.
@en
prefLabel
Population pharmacokinetics of ...... ct of pharmacogenetic factors.
@ast
Population pharmacokinetics of ...... ct of pharmacogenetic factors.
@en
P2093
P2860
P1476
Population pharmacokinetics of ...... ct of pharmacogenetic factors.
@en
P2093
Adam Frymoyer
Davide Verotta
Janel Long-Boyle
Pamala Jacobson
P2860
P304
P356
10.1111/J.1365-2125.2012.04372.X
P407
P577
2013-02-01T00:00:00Z